Company intelligence / Profile preview

Freya Biosciences

Copenhagen, Denmarkfreyabiosciences.com ↗

Ownership: Private
Employees: ~50
Development stage: Phase 1

Overview

Freya Biosciences has reported positive topline results from its first Phase 1 study of FB101, an investigational vaginal microbial immunotherapeutic. The company’s DYSCOVER™ platform has yielded promising candidates such as FB301 for improving pregnancy success rates in IVF. The company is advancing programs targeting bacterial vaginosis to prevent preterm birth and address other maternal health indications. Recent investments from the Bill & Melinda Gates Foundation validate their approach and support further development of their pipeline.[3][5]

Therapeutic areas: Infectious DiseasesWomen's Health
Modalities: Microbial immunotherapies[1][2][5]Live biotherapeutics (Lactobacillus strains)[2]
Industry: Biotech

Drug pipeline

8 assets

FB301

7 more assets in the full pipeline.

Request access →

Partnerships

Bill & Melinda Gates Foundation – strategic investment partnership focused on maternal/newborn health via BV/preterm birth therapies.[2]

Beyond the preview

Go deeper on Freya Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Freya Biosciences.

Explore the full profile